Non-Accredited Education
CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE
On Demand Web ArchiveNon-Accredited
Target Audience: Physicians, nurses, and technologists.
This activity is supported by an educational grant from Terumo Medical Corporation.
Vascular Disease News Wire
Hansen Medical Announces World's First Robotic Transvascular Aneurysm Repair
MOUNTAIN VIEW, Calif., – September 3, 2008 – Hansen Medical, Inc., (Nasdaq:
HNSN) the global leader in flexible robotics and the developer of robotic technology for
accurate 3D control of catheter movement, announced today that a team of physicians
led by Professor Nick Cheshire at St. Mary’s Hospital, part of the Imperial College
Healthcare NHS Trust, in London, England, utilized Hansen Medical’s Sensei™ Robotic
Catheter System and Artisan™ Control Catheter to aid deployment of stent grafts used
to treat an abdominal aorti
Global Vascular Interventional Leader Invatec Launches U.S. Operations
Invatec available at Booth 43 at VIVA Conference
Las Vegas, Nev. – September 23, 2008 – Invatec, a comprehensive innovator of vascular interventional products with global headquarters based in Italy, today announced at the annual VIVA (Vascular InterVentional Advances) conference that it has formally launched U.S. operations. Located in Bethlehem, PA, the U.S. headquarters is responsible for the sales, marketing, clinical, regulato
EKOS® Introduces New EkoSonic™ Endovascular System With Rapid Pulse™ Modulation Technology
Four Times Faster Than Conventional Catheter-Directed Thrombolysis
With no evidence of thrombus breakage or hemolysis
BOTHELL, WA – (BUSINESS WIRE) -- July 22, 2008 - EKOS Corporation announced today the launch of the EkoSonic™ Endovascular System (EkoSonic ES) with Rapid Pulse Modulation (RPM) for the dissolution of vascular blood clots. EkoSonic ES is the only endovascular system that can deliver microsonic energy and thrombolytic drugs simultaneously, providing a safer, faster and more complete way to remove clots by accelerating dissolution. The EkoSonic ES re
FDA Clears Possis AngioJet® System for Blood Clot Removal in Veins
Possis Medical, Inc. announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its AngioJet® Xpeedior® catheter to remove blood clots (thrombus) from upper- and lower-extremity peripheral veins. The Xpeedior catheter, which is used with Possis' world-leading AngioJet System, is the only device cleared for removing thrombus—a treatment known as thrombectomy—in peripheral veins.
Each year in the U.S., approximately 600,000 patients are diagnosed with deep vein thrombosis. Complications range from severe pain and limitation of mobility, to limb l
Georgetown University Medical Center First to Implant Patient with GORE PROPATEN Vascular Graft in the U.S. since Its FDA Cleara
W. L. Gore & Associates (GORE) announced that Georgetown University Hospital (GUH) in Washington, D.C. was the site of the first U.S. implant of the GORE PROPATEN Vascular Graft since its FDA clearance earlier this month. During a four-hour operation Richard Neville, M.D., chief of Vascular Surgery, GUH performed a bypass to save a patient's leg from amputation. The GORE PROPATEN Vascular Graft is the first synthetic vascular graft available in the U.S. that is designed to address the clinical problem of thrombotic vascular graft failure.
"Georgetown is thrilled to lead the way in this impo
FilterWire EZ™ Embolic Protection System Cleared by FDA for Cartoid Artery Stenting
Device now cleared for use in both carotid arteries and saphenous vein grafts
Boston Scientific Corporation announced it has received clearance from the U.S. Food and Drug Administration (FDA) to market its FilterWire EZ™ Embolic Protection System for use in carotid artery stenting (CAS) procedures. The device was cleared by the FDA in August 2004 for use in coronary saphenous vein graft (SVG) interventions and is currently the market-leading embolic protection device for carotid artery stenting procedures outside the U.S.
The FilterWire EZ System is designed to efficiently
First International Trial of Drug-Eluting Peripheral Artery Stent Results Encouraging
Cook Medical Releases Nine-Month Data for ZILVER® PTX Drug-Eluting Stent Trial at International Symposium on Endovascular Therapy (ISET)
Cook Medical’s ZILVER PTX Paclitaxel-Eluting Stent (DES) trial results demonstrated no stent fractures. The major adverse event (MAE) rate was equivalent to conventional balloon angioplasty treatment at its six-month follow-up point, as reported by the trial’s national principal investigator.
Michael Dake, M.D., national principal investigator for Cook's ZILVER® PTX Drug-Eluting Stent Trial, presented important nine-month data on the firs
ANGIODYNAMICS ANNOUNCES PLAN TO LAUNCH NEVERTOUCH™ VENACURE® PRODUCT LINE
Improved system will continue to serve varicose vein market
QUEENSBURY, N.Y. (April 2, 2007) – AngioDynamics, Inc. (NASDAQ: ANGO) announced today plans to launch the NeverTouch VenaCure procedure kit for laser treatment of severe varicose veins. The improved VenaCure design will employ a proprietary laser fiber technology designed to provide an enhanced level of perforation protection by further preventing contact between the fiber tip and the vessel wall during treatment.
The Company currently plans to implement its NeverTouch technology within the current fiscal quarter to e
Arrow International, Inc., to Provide Hand-Held Ultrasound for Vascular Access
Exclusive agreement with the Esaote Group for the InView™ Hand-Held Ultrasound System paves the way for future product development.
READING, Pa.--(BUSINESS WIRE)--Arrow International (NASDAQ: ARRO), the world’s leading provider of central venous catheter (CVC) products, has announced that it will distribute in the U.S. and Canada on an exclusive basis a new Hand-Held Ultrasound System for vascular access produced by Esaote, a leading worldwide manufacturer of medical diagnostic equipment based in Italy.
The InView Ultrasound System will complement the broadening range of access produ
Terumo Partners with GHX for More Efficient Electronic Ordering Capabilities
SOMERSET, NJ – Terumo Interventional Systems, a strategic business unit of Terumo Medical Corporation (TMC), announces a new partnership between TMC and Global Health Exchange (GHX); expanding its reputation for supplying technologically advanced quality to supply chain management.
Working with GHX and its Electronic Data Interchange (EDI) system, Terumo Interventional Systems is looking to deliver providers what they want—when they want it. Through this e-commerce platform’s unique, streamlined process, hospitals are now easily able to place orders, generate receipts, and change and
Digital Supplements Using Advanced Technology to |
 Superior Mesenteric Artery Revascularization and |
Vascular Disease News Wire
- Monday, October 6, 2008 - 11:02
- Monday, September 29, 2008 - 15:41
- Friday, September 12, 2008 - 11:06
Anytown, California
CME Showcase
 LUMEN 2009 - THE SYMPOSIUM ON OPTIMAL TREATMENTS FOR ACUTE MI Live Symposium Date: February 26-28 Location: Loews Miami Beach Hotel Miami Beach, Florida 33139 Phone: (305) 604-1601 Toll Free: 1-877-563-9762 This activity is sponsored by the North American Center for Continuing Medical Education. |
 CARDIAC PET: Optimizing CAD Patient Management with Diagnostic Confidence A Complimentary CME Accredited Lunch Symposium Date: Friday, September 12, 2008 12:00 pm - 1:15 pm Location: Hynes Convention Center 900 Boylston Street, Room 304 Boston, MA 02115 This activity is supported by an educational grant from Bracco Diagnostics Inc. |
REVIEW OUR OTHER
CARDIOLOGY BRANDS
Check out our other resources for healthcare professionals of all specialties.
